The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Advaxis; Amgen; AstraZeneca; Bayer; Cerulean Pharma; Debiopharm Group; GCI Health; Genmab; ImmunoGen; Janssen-Cilag; Lilly; Mateon Therapeutics; Morphotek; MSD; Nektar; Novartis Pharmaceuticals UK Ltd.; Novocure; Oncoinvent; Oxigene; Pfizer; Roche; Theradex Ltd; Vifor Pharma
Travel, Accommodations, Expenses - Elsevier; Tesaro; Theradex
AGO-OVAR 16: A phase III study to evaluate the efficacy and safety of pazopanib (PZ) monotherapy versus placebo in women who have not progressed after first line chemotherapy for epithelial ovarian, fallopian tube, or primary peritoneal cancer—Overall survival (OS) results.
 
Ignace Vergote
No Relationships to Disclose
 
Lars Christian Hanker
Consulting or Advisory Role - Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Anne Floquet
No Relationships to Disclose
 
Joern Rau
No Relationships to Disclose
 
Jae-Weon Kim
No Relationships to Disclose
 
Eugenia Ortega Izquierdo
No Relationships to Disclose
 
Michael Friedlander
Honoraria - AstraZeneca; MSD
Consulting or Advisory Role - AstraZeneca; MSD
Research Funding - BeiGene (Inst)
 
Sandro Pignata
Honoraria - AstraZeneca; MSD; pfizer; pharmamar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Pfizer; PharmaMar; Roche; tesaro
Research Funding - AstraZeneca (Inst); Roche (Inst)
 
Keiichi Fujiwara
Honoraria - Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; Janssen Oncology; Kyowa Hakko Kirin; Lilly Japan; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Zeria Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Eisai; MSD; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Kaken Pharmaceutical (Inst); Lilly (Inst); MSD (Inst); Oncotherapeutics (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Zeria Pharmaceutical (Inst)
 
Nicoletta Colombo
Employment - Ignyta (I)
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech
 
Mansoor Raza Mirza
Leadership - Karyopharm Therapeutics; SeraCare
Stock and Other Ownership Interests - Karyopharm Therapeutics; SeraCare
Honoraria - Advaxis; AstraZeneca; Cerulean Pharma; Clovis Oncology; Novocure; Pfizer; Roche; tesaro
Consulting or Advisory Role - AstraZeneca; Cerulean Pharma; Clovis Oncology; Genmab; Karyopharm Therapeutics; Novocure; Pfizer; Tesaro
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Karyopharm Therapeutics; Pfizer; Roche; SeraCare; Tesaro
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Abbvie; Advaxis; Amgen; AstraZeneca; Bayer; Biodesix; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Janssen; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Tesaro; Verastem; Vermillion
Consulting or Advisory Role - Abbvie; Advaxis; Amgen; AstraZeneca; Bayer; Biodesix; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Tesaro; Verastem; Vermillion
Speakers' Bureau - AstraZeneca; Clovis Oncology; Janssen; Roche/Genentech; Tesaro
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)
 
Manfred Mörtl
No Relationships to Disclose
 
Paula Calvert
Travel, Accommodations, Expenses - Pfizer; SERVIER
 
Thomas J. Herzog
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Johnson & Johnson; Roche/Genentech; Tesaro
 
Christian Jackisch
No Relationships to Disclose
 
Jérome Meunier
No Relationships to Disclose
 
Jung-Yun Lee
No Relationships to Disclose
 
Antje Kristina Belau
No Relationships to Disclose
 
Andreas Du Bois
Honoraria - PharmaMar; Tesaro
Consulting or Advisory Role - Advaxis; AstraZeneca; Genmab; Pfizer; Roche/Genentech